AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
AtriCure missed estimated earnings by 10.34%, reporting an EPS of $-0.32 versus an estimate of $-0.29.
Revenue was up $13.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 2.38% drop in the share price the next day.
Here's a look at AtriCure's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.29 | -0.33 | -0.33 |
| EPS Actual | -0.33 | -0.30 | -0.23 | -0.30 |
| Revenue Estimate | 71.17M | 72.65M | 68.68M | 61.07M |
| Revenue Actual | 74.58M | 73.22M | 70.46M | 71.38M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
AtriCure management provided guidance for FY 2022, expecting earnings between $-1.12 and $-1.07 per share.
To track all earnings releases for AtriCure visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
